Geode Capital Management, LLC Belite Bio, Inc Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Belite Bio, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 6,700 shares of BLTE stock, worth $393,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,700
Previous 6,700 -0.0%
Holding current value
$393,692
Previous $306,000 2.61%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$12.53 - $36.64 $83,951 - $245,488
6,700 New
6,700 $213,000
Q3 2022

Nov 14, 2022
BUY
$22.57 - $44.0 $163,948 - $319,616
7,264 New
7,264 $245,000

Others Institutions Holding BLTE

# of Institutions
16
Shares Held
79.1K
Call Options Held
0
Put Options Held
0
View Full List

About BELITE BIO, INC

BLTE Quotes by TradingView
  • Ticker BLTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,867,400
  • Market Cap $1.46B
  • Description
  • Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...
More about BLTE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email